About this study

This study investigates whether medicinal cannabis products that contain delta-9 tetrahydrocannabinol (THC) can be detected (present or absent) in saliva using roadside saliva drug testing equipment (Securetec Drugwipe® TWIN), and if so, for how long.

We will also look at how much THC is present in saliva, blood and urine, and assess driving and cognitive performance before and after using these products.

What’s involved?

Participants can be aged 21 and over, have a current (valid) prescription for a medicinal cannabis product that contains THC, and have a full driver's licence (no ‘P’ plates; recently expired licence is acceptable).  

Participants will be asked to attend Swinburne University for a seven-hour testing session. During the testing session, participants will consume their prescription medication as prescribed. They will be reimbursed for their time and travel expenses at the completion of the session.

Complete the registration form to participate

For further enquiries

The MCD team


Our research ethics and integrity

Our researchers are committed to the highest ethical, professional and scholarly standards. All our studies conform to the Australian Code for the Responsible Conduct of Research, Good Clinical Practice and the National Statement on Ethical Conduct in Human Research.

Explore more from our centre

Contact the Centre for Human Psychopharmacology

There are many ways to engage with us. If your organisation is dealing with a complex problem, get in touch to discuss how we can work together to provide solutions. Call us on +61 3 9214 4444 or email chp@swinburne.edu.au

Contact us